Sepsis due to Acinetobacter baumannii
ICD-10 A41.54 is a billable code used to indicate a diagnosis of sepsis due to acinetobacter baumannii.
Sepsis due to Acinetobacter baumannii is a severe systemic infection characterized by the presence of Acinetobacter baumannii, a gram-negative bacterium, in the bloodstream. This organism is known for its resilience and ability to survive in various environments, making it a common pathogen in healthcare-associated infections, particularly in intensive care units (ICUs). Patients with sepsis may present with symptoms such as fever, chills, rapid heart rate, and confusion, which can rapidly progress to septic shock, characterized by hypotension and multi-organ failure. The management of sepsis due to Acinetobacter baumannii often requires aggressive antimicrobial therapy, as this organism is frequently resistant to multiple antibiotics. Effective treatment necessitates timely identification through blood cultures and susceptibility testing, as well as supportive care in an ICU setting. Antimicrobial stewardship is crucial to prevent the development of further resistance and to optimize patient outcomes. Given the complexity of managing sepsis and the potential for rapid deterioration, healthcare providers must be vigilant in monitoring and documenting clinical changes to ensure appropriate coding and reimbursement.
Detailed documentation of culture results, resistance patterns, and treatment plans.
Patients presenting with fever and hypotension in the ICU, requiring broad-spectrum antibiotics.
Documentation must include rationale for antibiotic choice and adjustments based on culture results.
Comprehensive notes on hemodynamic status, organ function, and response to treatment.
Management of septic shock in patients with multi-organ failure.
Accurate recording of interventions and their timing is crucial for coding.
Used when obtaining cultures to identify Acinetobacter baumannii.
Document the source of the culture and the organism identified.
Infectious disease specialists should ensure cultures are obtained promptly in suspected sepsis cases.
Accurate coding of A41.54 is crucial for appropriate reimbursement, tracking of infection trends, and ensuring that patients receive the correct treatment based on their specific infection.
